Physicians' Academy for Cardiovascular Education

LDL cholesterol, the LDL receptor pathway & PCSK9

Sep. 10, 2016

Educational information

A mechanism of action animation on the potential role of the inhibition of PCSK9 with a monoclonal antibody.


Provided as an educational service by Regeneron /Sanofi

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: